OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Joost Boeckmans, Alexandra Gatzios, Jörn M. Schattenberg, et al.
Liver International (2023) Vol. 43, Iss. 5, pp. 975-988
Open Access | Times Cited: 17
Showing 17 citing articles:
PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies
Nuwayo Ishimwe Sincere, Krishnan Anand, Sumel Ashique, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4014-4014
Open Access | Times Cited: 39
Nuwayo Ishimwe Sincere, Krishnan Anand, Sumel Ashique, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4014-4014
Open Access | Times Cited: 39
Genetics of MASLD: The State of Art Update.
Silvia Sookoian, Yaron Rotman, Luca Valenti
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 11, pp. 2177-2187.e3
Closed Access | Times Cited: 15
Silvia Sookoian, Yaron Rotman, Luca Valenti
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 11, pp. 2177-2187.e3
Closed Access | Times Cited: 15
Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variants
Fernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, et al.
JHEP Reports (2024) Vol. 6, Iss. 7, pp. 101092-101092
Open Access | Times Cited: 9
Fernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, et al.
JHEP Reports (2024) Vol. 6, Iss. 7, pp. 101092-101092
Open Access | Times Cited: 9
Recent advances in MASLD genetics: Insights into disease mechanisms and the next frontiers in clinical application
Vincent Chen, Graham F. Brady
Hepatology Communications (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Vincent Chen, Graham F. Brady
Hepatology Communications (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
PNPLA3 Risk Allele Association With ALT Response to Semaglutide Treatment
Esteban Urias, Nicholas R. Tedesco, Antonino Oliveri, et al.
Gastroenterology (2023) Vol. 166, Iss. 3, pp. 515-517.e2
Open Access | Times Cited: 15
Esteban Urias, Nicholas R. Tedesco, Antonino Oliveri, et al.
Gastroenterology (2023) Vol. 166, Iss. 3, pp. 515-517.e2
Open Access | Times Cited: 15
Genetics of liver disease in adults
Chigoziri Konkwo, Shanin Chowdhury, Sílvia Vilarinho
Hepatology Communications (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 5
Chigoziri Konkwo, Shanin Chowdhury, Sílvia Vilarinho
Hepatology Communications (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 5
The Role of Exercise in Steatotic Liver Diseases: An Updated Perspective
Iyiad Alabdul Razzak, Ahmed Fares, Jonathan G. Stine, et al.
Liver International (2024) Vol. 45, Iss. 1
Closed Access | Times Cited: 5
Iyiad Alabdul Razzak, Ahmed Fares, Jonathan G. Stine, et al.
Liver International (2024) Vol. 45, Iss. 1
Closed Access | Times Cited: 5
Representation of Sex, Race and Ethnicity in MASH Randomised Controlled Trials: A Systematic Review and Meta‐Analysis
Matheus Souza, Lubna Al‐Sharif, Ivanna Diaz, et al.
Liver International (2025) Vol. 45, Iss. 4
Open Access
Matheus Souza, Lubna Al‐Sharif, Ivanna Diaz, et al.
Liver International (2025) Vol. 45, Iss. 4
Open Access
The importance of patient engagement in the multimodal treatment of MASLD
Joost Boeckmans, Hannes Hagström, Donna R. Cryer, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
Joost Boeckmans, Hannes Hagström, Donna R. Cryer, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
Unraveling Mechanisms of Genetic Risks in Metabolic Dysfunction–Associated Steatotic Liver Diseases: A Pathway to Precision Medicine
Xiang Zhang, Kyong‐Mi Chang, Jun Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2025) Vol. 20, Iss. 1, pp. 375-403
Closed Access
Xiang Zhang, Kyong‐Mi Chang, Jun Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2025) Vol. 20, Iss. 1, pp. 375-403
Closed Access
Human genetics of metabolic dysfunction–associated steatotic liver disease: from variants to cause to precision treatment
Vincent Chen, Annapurna Kuppa, Antonino Oliveri, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 7
Open Access
Vincent Chen, Annapurna Kuppa, Antonino Oliveri, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 7
Open Access
Gene-based therapies for steatotic liver disease
Viktoriia Iakovleva, Ype P. de Jong
Molecular Therapy (2025)
Closed Access
Viktoriia Iakovleva, Ype P. de Jong
Molecular Therapy (2025)
Closed Access
Global epidemiology and implications of PNPLA3 I148M variant in MASLD: a systematic review and meta-analysis
Matheus Souza, Lubna Al‐Sharif, Ivanna Diaz, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 15, Iss. 3, pp. 102495-102495
Closed Access | Times Cited: 3
Matheus Souza, Lubna Al‐Sharif, Ivanna Diaz, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 15, Iss. 3, pp. 102495-102495
Closed Access | Times Cited: 3
Obesity management for the hepatologist—What to do, how to do it and why?
Kymberly D. Watt, Sonali Paul, Mohammad Qasim Khan, et al.
Hepatology (2023)
Closed Access | Times Cited: 2
Kymberly D. Watt, Sonali Paul, Mohammad Qasim Khan, et al.
Hepatology (2023)
Closed Access | Times Cited: 2
Guidance and position of RINN22 regarding precision nutrition and nutriomics
Omar Ramos-López, Taís Silveira Assmann, Emili Muñoz, et al.
Lifestyle Genomics (2024), pp. 1-24
Open Access
Omar Ramos-López, Taís Silveira Assmann, Emili Muñoz, et al.
Lifestyle Genomics (2024), pp. 1-24
Open Access
Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities
Joost Boeckmans, Alexandra Gatzios, Jörn M. Schattenberg, et al.
Archives of Toxicology (2023) Vol. 97, Iss. 6, pp. 1825-1827
Open Access | Times Cited: 1
Joost Boeckmans, Alexandra Gatzios, Jörn M. Schattenberg, et al.
Archives of Toxicology (2023) Vol. 97, Iss. 6, pp. 1825-1827
Open Access | Times Cited: 1
Global epidemiology and implications of PNPLA3 I148M variant in MASLD: a systematic review and meta-analysis
Matheus Souza, Lubna Al‐Sharif, Ivanna Diaz, et al.
Research Square (Research Square) (2024)
Open Access
Matheus Souza, Lubna Al‐Sharif, Ivanna Diaz, et al.
Research Square (Research Square) (2024)
Open Access
Personalized treatment of metabolic (dysfunction-)associated fatty liver disease
Jan Clusmann, Kai Markus Schneider, Paul-Henry Koop, et al.
Deleted Journal (2023) Vol. 18, Iss. 4, pp. 300-307
Closed Access
Jan Clusmann, Kai Markus Schneider, Paul-Henry Koop, et al.
Deleted Journal (2023) Vol. 18, Iss. 4, pp. 300-307
Closed Access
